Skip to main content
. 2020 Aug 11;2020(8):CD008016. doi: 10.1002/14651858.CD008016.pub3

1.25. Analysis.

1.25

Comparison 1: Maintenance treatment with antipsychotic drugs versus placebo/no treatment, Outcome 25: Adverse effects: movement disorders: use of antiparkinson medication